Cure My Disease

Don't miss your cure!

 Log in / Sign up

AI speech coach boosts Kids' articulation in hybrid therapy trial

NCT ID NCT07061730

Disease control Sponsor: Syracuse University Source: ClinicalTrials.gov ↗

What the study statuses mean

This study's is highlighted.

Recruitment status, easiest to join first

Recruiting now
This trial is taking on new participants right now.
Not yet recruiting
Registered, but not yet taking participants.
By invitation only
Not open to general applications. Only people the study team invites can take part.
Paused
Paused for now. It may or may not start again.
Ongoing
Running, but no longer taking on new participants.
Completed
The trial has finished. Results may not be published yet.
Stopped early This study
Stopped early, before it reached the end. That can be for many reasons, including safety.
Cancelled
Cancelled before anyone took part.

Expanded access (not trials)

Expanded access
Not a trial. This treatment can be requested outside a study, case by case, for people who qualify.
Expanded access (paused)
Not a trial. The treatment can normally be requested outside a study, but is unavailable right now.
Expanded access (ended)
Not a trial. The treatment could once be requested outside a study, but no longer can.
Approved
The treatment has been approved, so it is available normally rather than through this programme.

When the status isn't known

Details not published
The full record has not been published yet, so there is little to show here.
Status unknown
This status has not been confirmed recently, so it may be out of date.

First seen Jul 09, 2026 · Last updated Jul 10, 2026 · Updated 1 time

Summary

This study tests whether adding an AI speech therapist, named Jessica, to traditional speech therapy helps children with speech sound disorders improve their articulation more than standard therapy alone. Over 8 weeks, children aged 5 to 17 receive weekly sessions with a speech-language pathologist, and some also practice with the AI between sessions. Researchers measure changes in speech accuracy and gather feedback from parents and therapists.

What this could mean

Our plain-language read of the trial. This is informational only, not medical advice or a prediction.

Active substance
AI speech therapist (Jessica) plus traditional speech therapy
What this could lead to
If successful, this could offer a more effective and accessible way to treat speech sound disorders in children, reducing the need for frequent in-person sessions.
What could go wrong
This is a small early-stage trial with only 23 participants, so results may not apply broadly. The AI tool may not work as well as human therapists, and technical issues could arise.

This is an AI summary of the original study and may miss details. Read our disclaimer.

Study facts

What this study's own registry entry says, in plain language.

Phase

Not a phased trial

Phase numbers describe drug development. The registry uses this when they do not apply, as it does for trials of devices, procedures or behaviour changes, and for observational studies.

Participants

23 people

The number who actually took part.

Started

May 2025

Finished

Feb 2026

Lead sponsor

Other sponsor

The registry's catch-all category, for sponsors it does not file as a company, a government agency, or a research network.

Who can take part

This study's own entry requirements. Only the study team can say for certain whether you qualify.

Ages

5 to 17 years

Sex

Anyone

Healthy volunteers

Not accepted

This study is not open to healthy volunteers. The entry requirements below say who it is open to.

Show the full entry requirements

Copied word for word from the study's registry entry, so the wording is the study team's rather than ours.

Inclusion Criteria: \- Response to be filled out by the Parent after sign up. * Does the child speak American English as one of their primary languages: Yes * At what age did the child first begin to learn English? Age 4 or younger * Child's current age: \> 5 years or \< 17 years 8 months * Does the child have any known history of any of the following: autism spectrum disorder, Down Syndrome, cerebral palsy, intellectual disability, permanent hearing loss, epilepsy/antiepileptic medication, or brain injury/neurosurgery/stroke: NO * Does the child have a diagnosis of ADD/ADHD, Tourette's Syndrome, or OCD? NO * Does the child currently have orthodontic appliances that block the roof of the mouth (e.g., palate expanders)? NO * Does the child currently have a cleft palate, fluency disorder (e.g., stuttering), or voice disorder? NO * Is one of your goals for your child to work on saying the "r" or "s" sounds? YES Exclusion Criteria: * EXCLUSIONARY Response to be filled out by the Parent after sign up. * Does the child speak American English as one of their primary languages: No * At what age did the child first begin to learn English? Age 4 or older * Child's current age: \<5 years or \> 17 years 8 months * Does the child have any known history of any of the following: autism spectrum disorder, Down Syndrome, cerebral palsy, intellectual disability, permanent hearing loss, epilepsy/antiepileptic medication, or brain injury/neurosurgery/stroke: YES * Does the child have a diagnosis of ADD/ADHD, Tourette's Syndrome, or OCD? YES * Does the child currently have orthodontic appliances that block the roof of the mouth (e.g., palate expanders)? YES * Does the child currently have a cleft palate, fluency disorder (e.g., stuttering), or voice disorder? YES * Is one of your goals for your child to work on saying the "r" or "s" sounds? NO

Get updates

Get notified about this study

Sign up to get updates when this study changes or when new studies for Speech sound disorder are added.

Our safety recommendation!

By submitting, you agree to our Terms of use

Conditions

The condition(s) this trial relates to.

Speech Sound Disorder speech-sound disorder

As listed by the trial registrant

The condition terms exactly as the trial's registrant entered them.

Speech sound disorder

Contacts and locations

Locations

  • Syracuse University

    Syracuse, New York, 13244, United States

More trials for these conditions

Other studies related to the condition(s) this trial covers.